Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazepam for prevention of febrile seizures after pertussis vaccination
IRCT20130311012782N24Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of diazepam in febrile seizure (FS) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Incidence of fever after pertussis vaccine injection and Incidence of seizure after pertussis vaccine injection. Started Jun 2015; status: completed.
02
Drugs
diazepam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20130311012782N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012782N24.